BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 32391417)

  • 41. Pediatric acute lymphoblastic leukemia with t(1;19)/TCF3-PBX1 in Taiwan.
    Yen HJ; Chen SH; Chang TY; Yang CP; Lin DT; Hung IJ; Lin KH; Chen JS; Hsiao CC; Chang TT; Chang TK; Peng CT; Lin MT; Jaing TH; Liu HC; Jou ST; Lu MY; Cheng CN; Sheen JM; Chiou SS; Hung GY; Wu KH; Yeh TC; Wang SC; Chen RL; Chang HH; Yang YL; Chen SH; Cheng SN; Chang YH; Chen BW; Hsieh YL; Huang FL; Ho WL; Wang JL; Chang CY; Chao YH; Lin PC; Chen YC; Liao YM; Lin TH; Shih LY; Liang DC
    Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28436581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression patterns of the hepatic leukemia factor gene in the nervous system of developing and adult mice.
    Hitzler JK; Soares HD; Drolet DW; Inaba T; O'Connel S; MG Rosenfeld ; Morgan JI; Look AT
    Brain Res; 1999 Feb; 820(1-2):1-11. PubMed ID: 10023025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. E2A-HLF usurps control of evolutionarily conserved survival pathways.
    Seidel MG; Look AT
    Oncogene; 2001 Sep; 20(40):5718-25. PubMed ID: 11607821
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ibrutinib is not an effective drug in primografts of TCF3-PBX1.
    van de Ven C; Boeree A; Stalpers F; Zwaan CM; Den Boer ML
    Transl Oncol; 2020 Oct; 13(10):100817. PubMed ID: 32563910
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of cooperative genes for E2A-PBX1 to develop acute lymphoblastic leukemia.
    Sera Y; Yamasaki N; Oda H; Nagamachi A; Wolff L; Inukai T; Inaba T; Honda H
    Cancer Sci; 2016 Jul; 107(7):890-8. PubMed ID: 27088431
    [TBL] [Abstract][Full Text] [Related]  

  • 46. E2A/HLF fusion gene in an acute lymphoblastic leukemia patient with disseminated intravascular coagulation and a normal karyotype.
    Dahéron L; Brizard F; Millot F; Cividin M; Lacotte L; Guilhot F; Brizard A
    Hematol J; 2002; 3(3):153-6. PubMed ID: 12111652
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian children.
    Kager L; Lion T; Attarbaschi A; Koenig M; Strehl S; Haas OA; Dworzak MN; Schrappe M; Gadner H; Mann G;
    Haematologica; 2007 Nov; 92(11):1561-4. PubMed ID: 18024406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two candidate downstream target genes for E2A-HLF.
    Kurosawa H; Goi K; Inukai T; Inaba T; Chang KS; Shinjyo T; Rakestraw KM; Naeve CW; Look AT
    Blood; 1999 Jan; 93(1):321-32. PubMed ID: 9864177
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Excellent outcome of acute lymphoblastic leukaemia with TCF3-PBX1 rearrangement in Hong Kong.
    Lin A; Cheng FWT; Chiang AKS; Luk CW; Li RCH; Ling ASC; Cheuk DKL; Chang KO; Ku D; Lee V; Ha SY; Li CK
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27346. PubMed ID: 30051646
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MEIS1 regulates an HLF-oxidative stress axis in MLL-fusion gene leukemia.
    Roychoudhury J; Clark JP; Gracia-Maldonado G; Unnisa Z; Wunderlich M; Link KA; Dasgupta N; Aronow B; Huang G; Mulloy JC; Kumar AR
    Blood; 2015 Apr; 125(16):2544-52. PubMed ID: 25740828
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia.
    Inaba T; Roberts WM; Shapiro LH; Jolly KW; Raimondi SC; Smith SD; Look AT
    Science; 1992 Jul; 257(5069):531-4. PubMed ID: 1386162
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conditional Expression of E2A-HLF Induces B-Cell Precursor Death and Myeloproliferative-Like Disease in Knock-In Mice.
    Duque-Afonso J; Smith KS; Cleary ML
    PLoS One; 2015; 10(11):e0143216. PubMed ID: 26588248
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of the t(17;19) translocation by gene-specific fluorescent in situ hybridization-based cytogenetics and detection of the E2A-HLF fusion transcript and protein in patients' cells.
    Yeung J; Kempski H; Neat M; Bailey S; Smith O; Brady HJ
    Haematologica; 2006 Mar; 91(3):422-4. PubMed ID: 16531271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of annexin II by cytokine-initiated signaling pathways and E2A-HLF oncoprotein.
    Matsunaga T; Inaba T; Matsui H; Okuya M; Miyajima A; Inukai T; Funabiki T; Endo M; Look AT; Kurosawa H
    Blood; 2004 Apr; 103(8):3185-91. PubMed ID: 15070701
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequency of the ETV6-RUNX1, BCR-ABL1, TCF3-PBX1, and MLL-AFF1 fusion genes in Guatemalan pediatric acute lymphoblastic leukemia patients and their ethnic associations.
    Carranza C; Granados L; Morales O; Jo W; Villagran S; Tinti D; Villegas M; Antillón F; Torselli S; Silva G
    Cancer Genet; 2013 Jun; 206(6):227-32. PubMed ID: 23859904
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia.
    Frismantas V; Dobay MP; Rinaldi A; Tchinda J; Dunn SH; Kunz J; Richter-Pechanska P; Marovca B; Pail O; Jenni S; Diaz-Flores E; Chang BH; Brown TJ; Collins RH; Uhrig S; Balasubramanian GP; Bandapalli OR; Higi S; Eugster S; Voegeli P; Delorenzi M; Cario G; Loh ML; Schrappe M; Stanulla M; Kulozik AE; Muckenthaler MU; Saha V; Irving JA; Meisel R; Radimerski T; Von Stackelberg A; Eckert C; Tyner JW; Horvath P; Bornhauser BC; Bourquin JP
    Blood; 2017 Mar; 129(11):e26-e37. PubMed ID: 28122742
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Meis2 as a critical player in MN1-induced leukemia.
    Lai CK; Norddahl GL; Maetzig T; Rosten P; Lohr T; Sanchez Milde L; von Krosigk N; Docking TR; Heuser M; Karsan A; Humphries RK
    Blood Cancer J; 2017 Sep; 7(9):e613. PubMed ID: 28960191
    [TBL] [Abstract][Full Text] [Related]  

  • 58. EP300-ZNF384 fusion gene product up-regulates GATA3 gene expression and induces hematopoietic stem cell gene expression signature in B-cell precursor acute lymphoblastic leukemia cells.
    Yaguchi A; Ishibashi T; Terada K; Ueno-Yokohata H; Saito Y; Fujimura J; Shimizu T; Ohki K; Manabe A; Kiyokawa N
    Int J Hematol; 2017 Aug; 106(2):269-281. PubMed ID: 28378055
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Concordance of two approaches in monitoring of minimal residual disease in B-precursor acute lymphoblastic leukemia: Fusion transcripts and leukemia-associated immunophenotypes.
    Huang YJ; Coustan-Smith E; Kao HW; Liu HC; Chen SH; Hsiao CC; Yang CP; Jaing TH; Yeh TC; Kuo MC; Lai CL; Chang CH; Campana D; Liang DC; Shih LY
    J Formos Med Assoc; 2017 Oct; 116(10):774-781. PubMed ID: 28063722
    [TBL] [Abstract][Full Text] [Related]  

  • 60. E2A-HLF chimeric transcription factors in pro-B cell acute lymphoblastic leukemia.
    Look AT
    Curr Top Microbiol Immunol; 1997; 220():45-53. PubMed ID: 9103674
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.